AF 647 NHS Ester
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 122663

CAS#: 407627-60-5 (free acid)

Description: AF 647 NHS Ester can be directly labeled to biomolecules such as primary antibodies, secondary antibodies peptides, etc.

Chemical Structure

img
AF 647 NHS Ester
CAS# 407627-60-5 (free acid)
Instruction

Theoretical Analysis

MedKoo Cat#: 122663
Name: AF 647 NHS Ester
CAS#: 407627-60-5 (free acid)
Chemical Formula: C40H46N3Na3O16S4
Exact Mass: 1,021.15
Molecular Weight: 1,022.020
Elemental Analysis: C, 47.01; H, 4.54; N, 4.11; Na, 6.75; O, 25.05; S, 12.55

Price and Availability

Size Price Availability Quantity
1mg USD 450 2 Weeks
5mg USD 1050 2 Weeks
Bulk inquiry

Related CAS #: 407627-60-5 (free acid)    

Synonym: 407627-60-5; AF 647 NHS Ester; BP Fluor 647 NHS Ester; BP-24069

IUPAC/Chemical Name: sodium 2-((1E,3E)-5-((E)-3,3-dimethyl-5-sulfonato-1-(3-sulfonatopropyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-3-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-3-methyl-1-(3-sulfonatopropyl)-3H-indol-1-ium-5-sulfonate

InChi Key: BMJDGMFKBUDRTQ-UHFFFAOYSA-K

InChi Code: InChI=1S/C40H49N3O16S4.3Na/c1-39(2)30-26-28(62(53,54)55)15-17-32(30)41(22-10-24-60(47,48)49)34(39)12-6-4-7-13-35-40(3,21-9-5-8-14-38(46)59-43-36(44)19-20-37(43)45)31-27-29(63(56,57)58)16-18-33(31)42(35)23-11-25-61(50,51)52;;;/h4,6-7,12-13,15-18,26-27H,5,8-11,14,19-25H2,1-3H3,(H3-,47,48,49,50,51,52,53,54,55,56,57,58);;;/q;3*+1/p-3

SMILES Code: CC1(CCCCCC(ON2C(CCC2=O)=O)=O)C(/C=C/C=C/C=C3N(CCCS(=O)(O[Na])=O)C4=C(C=C(C=C4)S(=O)(O[Na])=O)C/3(C)C)=[N+](CCCS(=O)([O-])=O)C5=CC=C(S(=O)(O[Na])=O)C=C15

Appearance: To be determined

Purity: >90% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 1,022.02 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. PMID: 34051178.


2: Karlsson JKG, Laude A, Hall MJ, Harriman A. Photo-isomerization of the Cyanine Dye Alexa-Fluor 647 (AF-647) in the Context of dSTORM Super-Resolution Microscopy. Chemistry. 2019 Nov 22;25(65):14983-14998. doi: 10.1002/chem.201904117. Epub 2019 Oct 24. PMID: 31515919.


3: Castelpietra G, Knudsen AKS, Agardh EE, Armocida B, Beghi M, Iburg KM, Logroscino G, Ma R, Starace F, Steel N, Addolorato G, Andrei CL, Andrei T, Ayuso-Mateos JL, Banach M, Bärnighausen TW, Barone-Adesi F, Bhagavathula AS, Carvalho F, Carvalho M, Chandan JS, Chattu VK, Couto RAS, Cruz-Martins N, Dargan PI, Deuba K, da Silva DD, Fagbamigbe AF, Fernandes E, Ferrara P, Fischer F, Gaal PA, Gialluisi A, Haagsma JA, Haro JM, Hasan MT, Hasan SS, Hostiuc S, Iacoviello L, Iavicoli I, Jamshidi E, Jonas JB, Joo T, Jozwiak JJ, Katikireddi SV, Kauppila JH, Khan MAB, Kisa A, Kisa S, Kivimäki M, Koly KN, Koyanagi A, Kumar M, Lallukka T, Langguth B, Ledda C, Lee PH, Lega I, Linehan C, Loureiro JA, Madureira- Carvalho ÁM, Martinez-Raga J, Mathur MR, McGrath JJ, Mechili EA, Mentis AA, Mestrovic T, Miazgowski B, Mirica A, Mirijello A, Moazen B, Mohammed S, Mulita F, Nagel G, Negoi I, Negoi RI, Nwatah VE, Padron-Monedero A, Panda-Jonas S, Pardhan S, Pasovic M, Patel J, Petcu IR, Pinheiro M, Pollok RCG, Postma MJ, Rawaf DL, Rawaf S, Romero-Rodríguez E, Ronfani L, Sagoe D, Sanmarchi F, Schaub MP, Sharew NT, Shiri R, Shokraneh F, Sigfusdottir ID, Silva JP, Silva R, Socea B, Szócska M, Tabarés-Seisdedos R, Torrado M, Tovani-Palone MR, Vasankari TJ, Veroux M, Viner RM, Werdecker A, Winkler AS, Hay SI, Ferrari AJ, Naghavi M, Allebeck P, Monasta L. The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990-2019: Findings from the Global Burden of Disease Study 2019. Lancet Reg Health Eur. 2022 Apr 1;16:100341. doi: 10.1016/j.lanepe.2022.100341. PMID: 35392452; PMCID: PMC8980870.


4: Meinel TR, Branca M, De Marchis GM, Nedeltchev K, Kahles T, Bonati L, Arnold M, Heldner MR, Jung S, Carrera E, Dirren E, Michel P, Strambo D, Cereda CW, Bianco G, Kägi G, Vehoff J, Katan M, Bolognese M, Backhaus R, Salmen S, Albert S, Medlin F, Berger C, Schelosky L, Renaud S, Niederhauser J, Bonvin C, Schaerer M, Mono ML, Rodic B, Tarnutzer AA, Mordasini P, Gralla J, Kaesmacher J, Engelter S, Fischer U, Seiffge DJ; Investigators of the Swiss Stroke Registry. Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation. Ann Neurol. 2021 Jan;89(1):42-53. doi: 10.1002/ana.25917. Epub 2020 Oct 17. PMID: 32996627; PMCID: PMC7756294.


5: Gebhardt C, Lehmann M, Reif MM, Zacharias M, Gemmecker G, Cordes T. Molecular and Spectroscopic Characterization of Green and Red Cyanine Fluorophores from the Alexa Fluor and AF Series*. Chemphyschem. 2021 Aug 4;22(15):1566-1583. doi: 10.1002/cphc.202000935. Epub 2021 Jun 29. PMID: 34185946; PMCID: PMC8457111.


6: Charitos EI, Stierle U, Ziegler PD, Baldewig M, Robinson DR, Sievers HH, Hanke T. A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions. Circulation. 2012 Aug 14;126(7):806-14. doi: 10.1161/CIRCULATIONAHA.112.098079. Epub 2012 Jul 23. Erratum in: Circulation. 2012 Sep 25;126(13):e216. PMID: 22824434.


7: Jia H, Wang W, Yu B. Efficacy and safety of low voltage area ablation for atrial fibrillation: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2022 Sep 3. doi: 10.1007/s10840-022-01258-1. Epub ahead of print. PMID: 36057055.


8: Herraiz-Martínez A, Tarifa C, Jiménez-Sábado V, Llach A, Godoy-Marín H, Colino-Lage H, Nolla-Colomer C, Casabella-Ramon S, Izquierdo-Castro P, Benítez I, Benítez R, Roselló-Díez E, Rodríguez-Font E, Viñolas X, Ciruela F, Cinca J, Hove-Madsen L. Influence of sex on intracellular calcium homoeostasis in patients with atrial fibrillation. Cardiovasc Res. 2022 Mar 16;118(4):1033-1045. doi: 10.1093/cvr/cvab127. PMID: 33788918; PMCID: PMC8930070.


9: Elferink H, Geurts K, Jue S, MacCormick S, Veeneman G, Boltje TJ. Synthesis and cellular uptake of carbamoylated mannose derivatives. Carbohydr Res. 2019 Jul 15;481:67-71. doi: 10.1016/j.carres.2019.06.008. Epub 2019 Jun 15. PMID: 31252337.


10: Chinthrajah RS, Cao S, Dunham T, Sampath V, Chandra S, Chen M, Sindher S, Nadeau K. Oral immunotherapy for peanut allergy: The pro argument. World Allergy Organ J. 2020 Sep 18;13(8):100455. doi: 10.1016/j.waojou.2020.100455. PMID: 33005286; PMCID: PMC7519204.


11: da Silveira MMBM, Cabral JVB, Souza BM, Hazime LHP, Araujo SLM, Xavier AT, Mendes Filho EB, Vasconcelos LRDS, Sobral Filho DC, de Oliveira DC. How Can Galectin-3 as a Biomarker of Fibrosis Improve Atrial Fibrillation Diagnosis and Prognosis? J Clin Med Res. 2020 Oct;12(10):647-654. doi: 10.14740/jocmr4313. Epub 2020 Sep 21. PMID: 33029271; PMCID: PMC7524564.


12: Betz K, Verhaert DVM, Gawalko M, Hermans ANL, Habibi Z, Pluymaekers NAHA, van der Velden RMJ, Homberg M, Philippens S, Hereijgers MJM, Vorstermans B, Simons SO, den Uijl DW, Chaldoupi SM, Luermans JGLM, Westra SW, Lankveld T, van Steenwijk RP, Hol B, Schotten U, Vernooy K, Hendriks JM, Linz D. Atrial fibrillation-specific refinement of the STOP-Bang sleep apnoea screening questionnaire: insights from the Virtual-SAFARI study. Clin Res Cardiol. 2023 Jun;112(6):834-845. doi: 10.1007/s00392-023-02157-9. Epub 2023 Feb 11. PMID: 36773038.


13: Kharbanda RK, Özdemir EH, Taverne YJHJ, Kik C, Bogers AJJC, de Groot NMS. Current Concepts of Anatomy, Electrophysiology, and Therapeutic Implications of the Interatrial Septum. JACC Clin Electrophysiol. 2019 Jun;5(6):647-656. doi: 10.1016/j.jacep.2019.04.013. PMID: 31221350.


14: Masunaga N, Ogawa H, Minami K, Ishigami K, Ikeda S, Doi K, Hamatani Y, Yoshizawa T, Ide Y, Fujino A, Ishii M, Iguchi M, Wada H, Hasegawa K, Tsuji H, Esato M, Abe M, Akao M; Fushimi AF Registry Investigators. Association of Concomitant Coronary Artery Disease With Cardiovascular Events in Patients With Atrial Fibrillation　- The Fushimi AF Registry. Circ J. 2022 Jul 25;86(8):1252-1262. doi: 10.1253/circj.CJ-22-0180. Epub 2022 Jul 1. PMID: 35786691.


15: Kornej J, Lin H, Trinquart L, Jackson CR, Ko D, Benjamin EJ, Preis SR. Neck Circumference and Risk of Incident Atrial Fibrillation in the Framingham Heart Study. J Am Heart Assoc. 2022 Feb 15;11(4):e022340. doi: 10.1161/JAHA.121.022340. Epub 2022 Feb 12. PMID: 35156385; PMCID: PMC9245798.


16: Khiabani AJ, MacGregor RM, Bakir NH, Manghelli JL, Sinn LA, Maniar HS, Moon MR, Schuessler RB, Melby SJ, Damiano RJ Jr. The long-term outcomes and durability of the Cox-Maze IV procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2022 Feb;163(2):629-641.e7. doi: 10.1016/j.jtcvs.2020.04.100. Epub 2020 May 5. PMID: 32563577; PMCID: PMC9810144.


17: Zaleska-Żmijewska A, Janiszewski M, Wawrzyniak ZM, Kuch M, Szaflik J, Szaflik JP. Is atrial fibrillation a risk factor for normal-tension glaucoma? Medicine (Baltimore). 2017 Oct;96(43):e8347. doi: 10.1097/MD.0000000000008347. PMID: 29069012; PMCID: PMC5671845.


18: Liu LM, Shen LS, Liu SY, Tu B, Li GL, Hu F, Hu ZC, Wu LM, Fan XH, Zheng LH, Ding LG, Yao Y. Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy. Chronic Dis Transl Med. 2020 Mar 13;6(1):35-45. doi: 10.1016/j.cdtm.2020.02.002. PMID: 32226933; PMCID: PMC7096325.


19: Zheng JY, Li DT, Qıu YG, Huang YX, Xu ZM, Zhao L, Chen Y, Cao Y, Tang YD, Guo CJ, Ma ZM, Wu YQ, Jıao Y, Li TC. CHA2DS2-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting. Turk J Med Sci. 2022 Aug;52(4):1103-1110. doi: 10.55730/1300-0144.5413. Epub 2022 Aug 10. PMID: 36326398.


20: Savelieva I, Camm J. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace. 2008 Jun;10(6):647-65. doi: 10.1093/europace/eun130. PMID: 18515286.